US70975L1070 - Common Stock
PENUMBRA INC
NYSE:PEN (4/25/2024, 9:23:41 AM)
203
-3.15 (-1.53%)
Penumbra, Inc. engages in the design, development, manufacture, and marketing of innovative medical devices. The company is headquartered in Alameda, California and currently employs 3,900 full-time employees. The company went IPO on 2015-09-18. The firm designs, develops, manufactures, and markets products and has a portfolio that focuses on medical conditions in markets with unmet need. The company is focused on developing, manufacturing, and marketing products for use by specialist physicians and healthcare providers. The company is focused on developing and building its portfolio of products, including its thrombectomy, embolization, access, and immersive healthcare technologies. The company has developed a product portfolio that includes seven product families within its major markets, in which its neuro products include Thrombectomy, Embolization, Access, and Neurosurgical Tools. Its vascular products include Thrombectomy and Embolization. The firm's immersive healthcare product is Immersive 3D Computer-based Technology Platform. The firm sells its products to hospitals and healthcare providers primarily through its direct sales organization in the United States, Europe, Canada and Australia.
PENUMBRA INC
One Penumbra Place
Alameda CALIFORNIA 94502
P: 15107483200
CEO: Adam Elsesser
Employees: 3900
Website: https://www.penumbrainc.com/
/PRNewswire/ -- Penumbra, Inc. (NYSE: PEN) today announced that it will host a conference call to discuss financial results for the first quarter 2024 after...
Penumbra (PEN) stock slips as J.P. Morgan downgrades the medical device company as its Q4 2023 revenue falls short of estimates. Read more here.
Here you can normally see the latest stock twits on PEN, but your cookie settings prevent this from loading. You can edit your cookie settings in our cookie consent dialog.
Example Twits: